Insiders Gossamer Bio, Inc.

Equities

GOSS

US38341P1021

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 20:43:40 18/05/2026 BST			5-day change	1st Jan Change
0.1950 ^USD	-42.65%		-39.95%	-93.44%

02:20pm	Gossamer Bio, Inc., Q1 2026 Earnings Call, May 18, 2026
12:07pm	Gossamer Bio launches exchange offer and consent solicitation intended to eliminate over $120 million of debt with existing noteholder support	RE

Insiders

12/03/24	Gossamer Bio Announces Board of Directors Appointments	CI
05/12/23	Gossamer Bio Inc. Appoints Bob Smith as Chief Commercial Officer	CI
29/11/23	Gossamer Bio, Inc. Appoints John Quisel to Its Board of Directors	CI
07/09/23	Gossamer Bio, Inc. Announces Resignation of Kristina Burow from the Board of Directors	CI
15/07/22	Insider Buy: Gossamer Bio	MT
24/03/22	Insider Sell: Gossamer Bio	MT
21/09/21	Gossamer Bio : Names Bryan Giraudo as Operations Chief	MT
21/09/21	Gossamer Bio Appoints Bryan Giraudo as Chief Operating Officer	CI
21/06/21	Gossamer Bio Announces Promotion of Richard Aranda, M.D., to Chief Medical Officer	CI
14/06/21	Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors	CI
20/04/21	Gossamer Bio, Inc. Announces Chief Scientific Officer Changes, Effective April 30, 2021	CI
16/04/21	Gossamer Bio, Inc. Announces Promotion of Caryn Peterson to Executive Vice President, Regulatory Affairs	CI
17/11/20	Gossamer Bio, Inc. Announces Executive Changes	CI
16/11/20	Gossamer Bio Announces Appointment of Faheem Hasnain as Chief Executive Officer	CI
13/09/19	Gossamer Bio, Inc. Announces Departure of Otello Stampacchia from its Board of Directors	CI
30/05/19	Gossamer Bio, Inc. Announces the Cessation of Faheem Hasnain as Executive Chairman and Transition to the Role of Non-Executive Chairman of the Board, Effective June 3, 2019	CI
19/12/18	Gossamer Bio, Inc. Announces Executive Changes	CI
17/12/18	Gossamer Bio, Inc. Announces Appointment of Jakob Dupont as Chief Medical Officer	CI
05/09/18	Gossamer Bio, Inc. Bio Announces Appointment of Luisa Salter-Cid as Chief Scientific Officer	CI
23/07/18	Gossamer Bio, Inc. Announces Executive Changes	CI